BrainCheck
PrivateLast Round
Series A
Feb 26, 2026
Total Funding Raised
$49M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BrainCheck operates in Healthcare & Life Sciences and is based in Austin, Texas. Its latest recorded funding round was a Series A round in February 2026.
BrainCheck is a healthcare technology company that provides a digital platform for cognitive assessment and care planning to help clinicians screen, monitor, and manage patient brain health.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Medical AI, EHR & EMR, Mental Health, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BrainCheck Comparables
Compare BrainCheck with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Linus Health | 89% | |
| Creyos | 86% | |
| Altoida, Inc. | 83% |
For institutional investors. Book with your work email.
BrainCheck Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 26, 2026 | ||||
| Series B Extension | Mar 6, 2024 | ||||
| Early Stage VC | Dec 21, 2023 | ||||
| Series B | Nov 3, 2021 | ||||
| Series A | Oct 9, 2019 | ||||
Seed | Oct 27, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BrainCheck Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nueterra Capital | Series B, Series A |
| Next Coast Ventures | Series A, Series B Extension, Series B, Early Stage VC |
| True Wealth Ventures | Seed, Series B, Series A |
| Texas Medical Center | Seed |
| Tensility Venture Partners | Series B, Series A |
| UPMC Enterprises | Series A, Series B, Series B Extension, Early Stage VC |
| S3 Ventures | Series A, Seed, Series B Extension, Series B, Early Stage VC |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Grew 31% QoQ, from 59 to 77 employees.
- Feb 26, 2026
$13M round completed.
For institutional investors. Book with your work email.
BrainCheck Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BrainCheck's valuation, stock price, and market status.
Is BrainCheck a public or private company?
BrainCheck is a private company.
What is the current stock price of BrainCheck?
BrainCheck is a private company, so its shares have no public market price. Caplight tracks BrainCheck's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BrainCheck worth (valuation)?
Valuation information for BrainCheck is not publicly available.
Can I buy BrainCheck stock?
BrainCheck shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BrainCheck's last funding round?
BrainCheck's most recent funding round was Series A on February 26, 2026.
Who are the main investors in BrainCheck?
Key investors in BrainCheck include Next Coast Ventures, Tensility Venture Partners, UPMC Enterprises, S3 Ventures.
Will BrainCheck IPO soon?
No public IPO plans have been announced for BrainCheck.
How can I track BrainCheck secondary market activity?
Caplight tracks bids, offers, and trades in BrainCheck's shares on secondary markets.